Biofrontera AG (BFAGY) Stock Analysis
DELISTED
What happened to Biofrontera AG (BFAGY) stock?
Biofrontera AG (BFAGY) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Biofrontera AG (BFAGY). Biofrontera AG is a biopharmaceutical company focused on dermatological products, including treatments for actinic keratoses and other skin conditions. The company markets its products in the United States, Europe, and Israel, with a focus on innovative therapies.
Last analyzed: Mar 17, 2026Biofrontera AG (BFAGY) Healthcare & Pipeline Overview
Biofrontera AG ADR Information Unsponsored
Biofrontera AG (BFAGY) trades in the U.S. as an American Depositary Receipt (ADR).
- ADR Level: 1
- ADR Ratio: 1:1
- Home Market Ticker: BFAG
BFAGY OTC Market Information
BFAGY trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy BFAGY shares?
No. BFAGY stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for BFAGY elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before BFAGY stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Biofrontera AG. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.